SEC Form 4 · accession 0001019056-16-001449
Aptevo Therapeutics Inc. · APVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Marvin L White
Officer — President and CEO · Director
Period of report
Aug 3, 2016
Accepted (ET)
Aug 5, 2016 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001671584
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.94 | Aug 3, 2016 | A | 200,475 | A | — | Aug 3, 2026 | Common Stock | 200,475 | 200,475 | D |
Explanation of responses
- F1The stock options were granted on August 3, 2016 and vest in three equal installments on August 3, 2017, August 3, 2018 and August 3, 2019.